Publication Cover
Synthetic Communications
An International Journal for Rapid Communication of Synthetic Organic Chemistry
Volume 51, 2021 - Issue 20
262
Views
2
CrossRef citations to date
0
Altmetric
Articles

Novel pyrazole derivatives via ring transformations: Anti-inflammatory and antifungal activity studies

, , , , , & ORCID Icon show all
Pages 3125-3140 | Received 02 Apr 2021, Published online: 06 Sep 2021
 

Abstract

In this paper, the synthesis of novel pyrazoles and their in vitro anti-inflammatory and in-vitro antifungal assay have been reported. These compounds were docked into the inducible nitric oxide synthase (iNOS) oxygenase dimer. The compounds 3c, 7a, 7c, 8a, 8c have exhibited the C-score values more than the standard drug aminoguanidine (5.35). Upon the favorable docking results, the anti-inflammatory potential of the title compounds was determined by analyzing the reduction in the NO production by activated macrophages using in-vitro assays. The compounds 4c, 5c, 6a, 6c, 7a, 8a, 8c exhibited the potential anti-inflammatory activity at 1.00 µg/mL. Further, the docking study of the title compounds 3b, 3c, 4a, 5a, 5c with Aspergillus fumigatus N-myristoyl transferase (NMT) showed appreciable C-score values as against that of fluconazole (5.56). This observation was further substantiated by in-vitro antifungal activity in which the compounds 3b–c, 4a–c, 5a–c, 6a–c, 7ab, 9a–c have excellent inhibition against A. fumigatus.

Graphical Abstract

Acknowledgments

The authors wish to thank the DST, Govt of India New Delhi for providing grants under DST-PURSE Phase II and DST-SAIF to Karnatak University Dharwad. The authors acknowledge the University Scientific Instrumentation Centre (USIC), Karnatak University, Dharwad, NMR Research Centre, Indian Institute of Science (IISc), Bengaluru, India for carrying out the spectral analyses.

Additional information

Funding

This study was supported by DST, SAIF [SR/RS/DH-1/20132 Dt:15/05/2013]; DST, New Delhi [Purse Phase II].

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.